Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02846012 · ClinicalTrials.gov registry record · NA
Comparison of Culture Media for in Vitro Embryo Development
A NA study, sponsored by Ovation Fertility.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02846012: Completed NA study, sponsored by Ovation Fertility.
NCT02846012 is a NA study that has completed, run by Ovation Fertility. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02846012, a NA study, has completed, sponsored by Ovation Fertility.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to collect development and outcome data on human embryos which are cultured in a 2nd generation continuous single culture medium (CSCM2) with the objective to demonstrate its performance efficacy in comparison to existing commercially available single culture or continuous embryo culture media.
Primary Outcome
Live Birth
Interventions
- OTHER CSCM2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-12-22 |
| Phase | NA |
What the finished NCT02846012 record still lists
NCT02846012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which CSCM2 is the first listed.
NCT02846012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02846012 about?
NCT02846012 is a clinical study titled "Comparison of Culture Media for in Vitro Embryo Development". The purpose of this study is to collect development and outcome data on human embryos which are cultured in a 2nd generation continuous single culture medium (CSCM2) with the objective to demonstrate its performance efficacy in comparison to existing commercially available single culture or continuo...
What is the current status of trial NCT02846012?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-05. Estimated completion is 2017-12-22.
What interventions are being tested in trial NCT02846012?
The interventions under investigation include: CSCM2 (OTHER).
Who is sponsoring clinical trial NCT02846012?
This trial is sponsored by Ovation Fertility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02846012's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia